Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects

NCT03178422 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: CQSS2
DRUG: NicoDerm CQ Patch

Sponsor

Chrono Therapeutics, Inc.